Global Information
회사소개 | 문의 | 비교리스트

인간성장호르몬(HGH) 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2020-2025년)

Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

리서치사 IMARC Services Private Limited
발행일 2020년 06월 상품 코드 945224
페이지 정보 영문 110 Pages
가격
US $ 2,299 ₩ 2,710,000 PDF (Single User License)
US $ 3,399 ₩ 4,006,000 PDF (5 User License)
US $ 4,499 ₩ 5,303,000 PDF (Corporate License)


인간성장호르몬(HGH) 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2020-2025년) Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
발행일 : 2020년 06월 페이지 정보 : 영문 110 Pages

세계의 인간성장호르몬(HGH) 시장은 현재 안정된 성장을 보이고 있으며, 2020-2025년 약 6%의 CAGR로 성장할 것으로 예측되고 있습니다. HGH는 하수체에 의해 생성되는 어린이 및 성인의 성장을 자극하는 펩티드 호르몬입니다. 호르몬은 주로 세포의 성장, 재생, 수복, 생식, 대사를 조절하고, 신체 전체의 발달에 기여 합니다. 또한 체액, 지방 대사, 뼈 및 근육의 성장을 조절합니다. HGH의 결핍은 질병 및 지방 축적 리스크를 높일 가능성이 있으나, 과잉 레벨은 어린이에게 거인증, 말단 비대증, 성인기에 근위축성 질환 및 단장증후군을 일으킬 가능성이 있습니다.

터너 증후군 및 기타 성장 관련 장애의 유병률 증가는 시장 성장을 촉진하는 주요 요인 중 하나입니다. 터너 증후군은 주로 여성에게 영향을 미치는 염색체 장애로, X염색체의 완전 또는 부분적인 상실을 특징으로 합니다. 성장호르몬은 이 질병의 증상을 다소 역전시키기 위해 종종 투여되며, 이에 따라 전 세계 HGH약의 수요가 증가합니다. 또한 사람들의 건강 인식 향상과 내분비 장애 예방책에 관한 인식의 향상이 시장 성장을 지원하고 있습니다. 프라더-윌리 증후군(PWS) 및 특발성저신장(ISS) 등 다양한 장애는 체내의 성장 호르몬 결핍에 의해 발생하나, 의학적으로 합성된 HGH를 사용하여 치료할 수 있습니다. 보디빌더에 의한 퍼포먼스 인핸서로서 HGH의 이용률 상승, 재조합 인간성장호르몬(rHGH)의 개발 등의 기타 요인이 시장을 한층 더 촉진할 것으로 예측됩니다.

세계의 인간성장호르몬(HGH) 시장에 대해 조사했으며, 업계 동향, 시장 예측, 애플리케이션·유통 채널·투여 경로별·최종 용도 산업·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 범위와 조사 방법

제3장 개요

제4장 서론

제5장 세계의 인간성장호르몬 시장

  • 시장 개요
  • 시장 성과

제6장 애플리케이션별 시장

  • 성장호르몬(GH) 결핍증
    • 주요 유형
  • 터너 증후군
  • 특발성저신장(ISS)
  • 프라더-윌리 증후군(PWS)
  • SGA(Small for Gestational Age)
  • 기타

제7장 유통 채널별 시장

  • 병원 약국
  • 소매 약국
  • 온라인 약국
  • 기타

제8장 투여 경로별 시장

  • 정맥내
  • 근육내
  • 피하
  • 경구

제9장 지역별 시장

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동·아프리카
    • 국가별 시장별

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter의 산업 분석

제13장 경쟁 구도

  • 시장 구조
  • 주요 기업
  • 주요 기업의 개요
    • Eli Lilly and Company
    • EMD Serono Inc.
    • F. Hoffmann-La Roche AG
    • Ferring B.V.
    • Genentech Inc.
    • Ipsen
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk
    • Pfizer Inc.
    • Sandoz
KSA 20.07.10

List of Figures

  • Figure 1: Global: Human Growth Hormone Market: Major Drivers and Challenges
  • Figure 2: Global: Human Growth Hormone Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Human Growth Hormone Market: Breakup by Application (in %), 2019
  • Figure 4: Global: Human Growth Hormone Market: Breakup by Distribution Channel (in %), 2019
  • Figure 5: Global: Human Growth Hormone Market: Breakup by Route of Administration (in %), 2019
  • Figure 6: Global: Human Growth Hormone Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Human Growth Hormone Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Human Growth Hormone (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Human Growth Hormone (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Human Growth Hormone (Turner Syndrome) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Human Growth Hormone (Turner Syndrome) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Human Growth Hormone (Small for Gestational Age) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Human Growth Hormone (Small for Gestational Age) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Human Growth Hormone (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Human Growth Hormone (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Human Growth Hormone (Hospital Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Human Growth Hormone (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Human Growth Hormone (Retail Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Human Growth Hormone (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Human Growth Hormone (Online Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Human Growth Hormone (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Human Growth Hormone (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Human Growth Hormone (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: North America: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: North America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: United States: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: United States: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: Canada: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: Canada: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Asia Pacific: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Asia Pacific: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: China: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: China: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Japan: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Japan: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: India: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: India: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: South Korea: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: South Korea: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: Australia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: Australia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Indonesia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Indonesia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Europe: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Europe: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Germany: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Germany: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: France: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: France: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: United Kingdom: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: United Kingdom: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: Italy: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: Italy: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: Spain: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: Spain: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Russia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Russia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Latin America: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Latin America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Brazil: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Brazil: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Mexico: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Mexico: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Middle East and Africa: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Middle East and Africa: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Global: Human Growth Hormone Industry: SWOT Analysis
  • Figure 77: Global: Human Growth Hormone Industry: Value Chain Analysis
  • Figure 78: Global: Human Growth Hormone Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Growth Hormone Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Human Growth Hormone Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 3: Global: Human Growth Hormone Market Forecast: Breakup by Distribution Channel (in Million US$), 2020-2025
  • Table 4: Global: Human Growth Hormone Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
  • Table 5: Global: Human Growth Hormone Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 6: Global: Human Growth Hormone Market: Competitive Structure
  • Table 7: Global: Human Growth Hormone Market: Key Players

The global human growth hormone market (HGH) is currently witnessing strong growth. HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. The hormone primarily regulates growth, regeneration, repair, reproduction and metabolism of the cells, thus contributing to the overall development of the body. It also regulates body fluids, fat metabolism and bone and muscle growth. The deficiency of HGH can increase the risk of diseases and fat accumulation, whereas higher levels can cause gigantism in children and acromegaly, muscle-wasting disease and short bowel syndrome in adults.

The increasing prevalence of Turner syndrome and other growth-related disorders is one of the key factors driving the growth of the market. Turner syndrome is a chromosomal disorder that primarily affects females and is characterized by complete or partial loss of X chromosomes. Growth hormones are often administered to reverse some of the symptoms of this disease, thereby increasing the demand for HGH drugs across the globe. Furthermore, increasing health consciousness among the masses and growing awareness regarding the preventive measures against endocrine disorders, are providing a boost to the market growth. Various disorders, such as Prader-Willi syndrome (PWS) and idiopathic short stature (ISS), are caused by the deficiency of growth hormones in the body that can be treated using medically synthesized HGH. Other factors, including a rising utilization of HGH as performance enhancers by bodybuilders, along with the development of recombinant human growth hormone (rHGH), are projected to drive the market further. Looking forward, IMARC Group expects the market to register a CAGR of around 6% during 2020-2025.

Breakup by Application:

  • Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature (ISS)
  • Prader-Willi Syndrome (PWS)
  • Small for Gestational Age
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Breakup by Route of Administration:

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.

Key Questions Answered in This Report:

  • How has the global human growth hormone market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global human growth hormone market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Growth Hormone Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Application

  • 6.1 Growth Hormone (GH) Deficiency
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Market Types
      • 6.1.2.2 Market Types
    • 6.1.3 Market Forecast
  • 6.2 Turner Syndrome
    • 6.2.1 Market Trends
    • 6.2.1 Market Forecast
  • 6.3 Idiopathic Short Stature (ISS)
    • 6.3.1 Market Trends
    • 6.3.1 Market Forecast
  • 6.4 Prader-Willi Syndrome (PWS)
    • 6.4.1 Market Trends
    • 6.4.1 Market Forecast
  • 6.5 Small for Gestational Age
    • 6.5.1 Market Trends
    • 6.5.1 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.1 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Subcutaneous
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Oral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Eli Lilly and Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 EMD Serono Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Ferring B.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Genentech Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Ipsen
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Novo Nordisk
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sandoz
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

Back to Top
전화 문의
F A Q